Results 261 to 270 of about 228,880 (307)
Some of the next articles are maybe not open access.

CRISPR/Cas9

2017
CRISPR/Cas9 is a novel method that has become the most widely used genome editing technology around the world. Its widespread adoption is largely due to its simplicity and easy of use. Here, we introduce the construction of vectors and genome editing of the target gene in cells expressing the CRISPR/Cas9 system.
Izuho, Hatada, Takuro, Horii
openaire   +3 more sources

Cas9 gets a classmate

Nature Biotechnology, 2015
Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.
Erik J, Sontheimer, Scot A, Wolfe
openaire   +2 more sources

A Broad-Spectrum Inhibitor of CRISPR-Cas9

open access: yesCell, 2017
CRISPR-Cas9 proteins function within bacterial immune systems to target and destroy invasive DNA and have been harnessed as a robust technology for genome editing.
Joshua C Cofsky   +2 more
exaly   +2 more sources

CAS9-CAS9 FUSION PROTEINS

2021
WOLFE SCOT ANDREW   +4 more
openaire   +2 more sources

CRISPR–Cas9 Wins Nobel

Nature Reviews Molecular Cell Biology, 2020
Paulina Strzyz
exaly  

Cas9

2022
openaire   +1 more source

Cas9 in close-up

Nature Biotechnology, 2014
Erin L, Garside, Andrew M, MacMillan
openaire   +2 more sources

Structural Basis for Cas9 Off-Target Activity

Cell, 2022
Martin Jínek, Katja Bargsten
exaly  

Home - About - Disclaimer - Privacy